The Quick-Glia™ Astrocyte – SeV Kit facilitates rapid and efficient differentiation of human iPS or ES cells into astrocyte cells. Quick-Glia™ Astrocyte differentiated cell cultures display typical astrocyte morphology and markers such as S100 Calcium Binding Protein ß (S100ß), Chondroitin Sulfate Proteoglycan 8 (CD44), Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1), and mature astrocyte marker […]
Our Quick-Neuron™ Sensory differentiated cell cultures display typical neurite outgrowth and express a variety of neuronal markers, such as tubulin beta 3 class III (TUBB3) and variety of sensory neuron markers such as peripherin (PRPH), islet-1 (ISL1), and brain-specific homeobox/POU domain protein 3A (BRN3A/POU4F1). • Differentiation achieved in just 10 days • Proprietary transcription factor-based […]
Our Quick-Neuron™ Precursor – Human iPSC-derived Neural Precursor Cells (NPCs) proliferate and express a variety of NPC markers, such as neuroectodermal stem cell marker, Nestin (NES) and Vimentin (VIM). • Available from multiple healthy and patient iPSC lines • Proprietary transcription factor-based stem cell differentiation • No genetic footprint • Viable long-term • Suitable for […]
The Quick-Neuron™ GABAergic – mRNA Kit (Small) facilitates rapid and efficient differentiation of human iPS or ES cells into a population of primarily GABAergic neurons. Quick-Neuron™ GABAergic differentiated cell cultures display typical neurite outgrowth and express a variety of neuronal markers, such as the pan-neuronal marker tubulin beta 3 class III (TUBB3) and the GABAergic […]
The Quick-Endothelium™ Vascular – mRNA Kit (Small) facilitates rapid and efficient differentiation of human iPS or ES cells into vascular endothelial cells. Cell cultures display typical endothelial morphology and capillary tube formation, and express the endothelial cell markers cluster of differentiation 31 (CD31) and von Willebrand factor (vWF) as well as the tight junction marker […]
Elixirgen Scientific’s Director of Molecular Biology Tetsuya Tanaka, Ph.D. webinar presented at the 2020 BIO Innovation Conference on accelerating drug discovery with our rapid iPSC differentiation technology.
TOKYO/BALTIMORE, Aug. 28, 2020 – Elixirgen Scientific announced today that it has entered into a master service agreement (MSA) with Otsuka Pharmaceuticals. Elixirgen Scientific provides Otsuka Pharmaceuticals with its proprietary Quick-Tissue™ differentiation technology that enables rapid and highly efficient differentiation of human induced pluripotent stem cells (hiPSCs) for deeper understanding on human disease biology in […]
Elixirgen Scientific, Inc. is pleased to announce the opening of a new Japanese office located in Kawasaki city, Kanagawa Prefecture. The Japan office will allow Elixirgen Scientific to support a growing demand for induced pluripotent stem cell (iPSC) differentiation technologies in Japan and throughout the Asia/Pacific region. This is an important milestone as it is the […]